Showing results (111-120 of 145) with videos related to
Sort By:
Pageof 15
The American Journal of Pathology|December 6, 2002
Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formationSimone Schmid, Petra C Kuechler, Markus Britschgi, et al.Pharmacoeconomics|January 31, 2009
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphomaPhilippe Fagnoni, Noel Milpied, Samuel Limat, et al.Journal Francais D'Ophtalmologie|August 1, 2022
Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathyM H Le Nguyen, M S Naoum, C Andre, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaS Limat, K Demesmay, L Voillat, et al.Pharmacy World & Science : PWS|March 29, 2003
Antidepressant response and fluvoxamine plasma concentrations: a pilot studyFlorence Schwarzenbach, Christian Netillard, Patricia Demoly, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 24, 2025
Carbon footprint of a chemotherapy production unit within a hospital pharmacy: Time for green pharmacyManon Chabane, Christine Fagnoni-Legat, Camille Hosotte, et al.Pharmacy World & Science : PWS|December 24, 2003
Observational study of potential risk factors of medication administration errorsEdgar Tissot, Christian Cornette, Samuel Limat, et al.Bulletin Du Cancer|August 29, 2006
[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification]Philippe Fagnoni, Samuel Limat, Estelle Hintzy-Fein, et al.Bulletin Du Cancer|November 1, 2006
[Appropriate cytotoxic drug usages in solid tumors: conformity to official labelling and level of scientific evidence]Ludwig Grangeasse, Bruno Coudert, Xavier Pivot, et al.American Journal of Clinical Oncology|April 1, 2008
A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapiesErika Viel, Martin Frederico Demarchi, Loic Chaigneau, et al.Pageof 15